Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
486.50    40.00 (8.96%)
Bid:
486.00
Ask:
487.50
Spread: 1.50 (0.309%)
Market Cap: £168.98m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

EBT and Director Dealings

26 Oct 2015 12:35

RNS Number : 4448D
Frontier Developments PLC
26 October 2015
 



26 October 2015

Frontier Developments plc

(the "Company")

 

EBT and Director Dealings

 

Frontier Developments plc (AIM: FDEV, "Frontier", the "Group"), a leading developer of video games, announces the following dealings of which it was notified today:

 

EBT Dealings

 

Appleby Trust (Jersey) Limited, the trustee of the Frontier Developments plc Employee Share Ownership Plan Trust (the "EBT"), that the EBT transferred 152,000 shares to meet employee share option awards at an average exercise price of 0.6947 pence per Ordinary Share.

Following this exercise of options, 56,072 were repurchased by the EBT at 230.0 pence per share to meet the exercise price and individuals' associated tax liabilities. The balance of 95,928 shares are to be transferred to employees.

 

 

Following this transaction, the EBT is interested in 241,927 Ordinary Shares, representing 0.7 per cent of the Company's total issued share capital.

 

The EBT is a discretionary trust for the benefit of employees of the Company and its subsidiaries, who have been granted share options. The Executive Directors of the Company are included in the class of potential beneficiaries of the EBT and are deemed to be interested in those shares and the dealings thereof.

 

Director Dealings

 

Jonathan Watts, Chief Creative Officer has today exercised share options of 30,000 ordinary shares of 0.5p each at an exercise price of 67 pence per Ordinary Share.

 

Neil Armstrong, Chief Financial Officer (an applicable employee under the AIM rules) has today exercised share options of 12,500 at an exercise price of 89 pence per Ordinary Share.

 

Following the exercise of these options Mr Watts and Mr Armstrong sold 19,370 Ordinary Shares and 7,474 Ordinary Shares respectively at a price of 230p per Ordinary Share to meet the exercise price and any associated tax liabilities.

 

Following the options exercise and related sale the interests of Mr. Watts and Mr. Armstrong are as follows:

 

Director

Number of Ordinary Shares prior to transaction

Number of Ordinary Shares post transaction

Total interest in Ordinary Shares as % of issued share capital

Jonathan Watts

44,760

55,390

0.2%

Neil Armstrong

26,163

31,189

0.1%

 

Enquiries:

 

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

David Walsh, COO

Neil Armstrong, CFO

 

 

 

 

Numis - Nomad and Joint Broker

+44 (0)20 7260 1000

Simon Willis / Jamie Lillywhite / Rupert Krefting

 

 

 

Finncap

 

+44 (0) 207 220 0500

Matt Goode/Giles Rolls

 

 

 

 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White/Matt Low

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNOURVOARUAA
Date   Source Headline
10th Jun 20267:00 amRNSCMS STRATEGY DELIVERS RECORD FINANCIAL RESULTS
8th Jun 20261:54 pmRNSEBT Share Purchase
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.